JD HEALTH Aktie

 

Market survey results over the past three years on China's pharmaceutical retail sector showed consumers' acceptance of online channels continued to rise, mainly due to greater convenience, more competitive pricing, and wider product selection versus offline formats, UBS said in a research report. The broker forecast onl......

JD HEALTH (06618.HK) repurchased a total of 500,000 shares of the company on the Hong Kong Stock Exchange on June 26, at prices ranging from HKD31.84 to HKD32.68 per share, involving HKD16.0247 million, disclosure filings showed. Since the repurchase mandate was approved, the group has cumulatively bought back 20.9424 million sh......

JD HEALTH (06618.HK) announced that it has signed a strategic cooperation agreement with Harbin Pharmaceutical Group. The two parties will deepen collaboration in areas including exclusive launch of new drugs, AI-powered precision recommendations, patient education, and full disease-cycle management, while systematically upgradi......

JD HEALTH (06618.HK) repurchased approximately 225,400 shares on the Stock Exchange last Friday (5th), at prices ranging from HKD37.62 to HKD37.8 per share, involving approximately HKD8.4984 million.Since the repurchase mandate resolution was passed (20 June 2025), the company has repurchased approximately 16.171 million shares ......

JD HEALTH (06618.HK) repurchased approximately 2.529 million shares on the Stock Exchange yesterday (28th), at prices ranging from HKD38.04 to HKD40.3 per share, involving approximately HKD96.9235 million.Since the share repurchase mandate was approved on 20 June 2025, the company has repurchased approximately 15.9456 million sh......

JD HEALTH (06618.HK) repurchased approximately 2.5435 million shares on the Stock Exchange yesterday (26 May), at prices ranging from HKD38.44 to HKD40.02 per share, involving approximately HKD101 million.Since the repurchase mandate was approved (20 June 2025), the company has repurchased approximately 11.6144 million shares in......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

JD HEALTH (06618.HK) repurchased approximately 1.9332 million shares on the Stock Exchange yesterday (21st), at prices ranging from HKD39.78 to HKD40.5 per share, involving approximately HKD77.5394 million.Since the repurchase mandate was approved on 20 June 2025, the company has repurchased approximately 8.3416 million shares i......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

JD HEALTH (06618.HK) reported 1Q revenue growth of 17% YoY, in line with the broker's expectations, Nomura said in a research report. Non-IFRS operating profit grew 48% YoY to RMB1.9 billion, on the ride of gross margin expansion due to enhanced supply chain capabilities and faster growth in high-margin advertising revenue. ......

JD HEALTH (06618.HK) opened 1.16% lower today, hitting an intraday trough of HKD45.68. It last quoted at HKD45.74, down 5.42%, with turnover of 5.9154 million shares, involving HKD275 million.Nomura issued a research report stating that JD HEALTH's pharmaceutical sales impetus continued and operating profit remained strong. ......

HSBC Research said in a report that JD HEALTH (06618.HK)'s supplement business slowed in April due to tighter regulation, but signs of recovery emerged in May. The broker believes the slowdown in supplement demand is only temporary. It also noted that JD HEALTH's newly announced dual share buyback plan supports valuation. As a r......

JD HEALTH (06618.HK) reported that its 1Q26 non-IFRS net profit added 6% YoY to RMB1.874 billion. The company plans to repurchase shares of up to USD1 billion. The stock opened 3.43% higher this morning (13th) at HKD47, with 141,100 shares traded pre-market, involving HKD6.6293 million. ~AASTOCKS Financial NewsWebsite: www.aasto......

JD HEALTH (06618.HK) announced that the Board has authorized and approved a program to repurchase up to USD1 billion in value of the shares of the Company from the open market over a 48-month period starting from the approval date.The Board believed that the Proposed Share Repurchase in the present conditions will demonstrate th......

JD HEALTH (06618.HK) announced its operating results for 1Q26 ended late March. Operating profit rose 70.4% YoY to RMB1.825 billion. Non-IFRS operating profit increased 48% YoY to RMB1.936 billion. Non-IFRS net profit grew 6% YoY to RMB1.874 billion. Revenue rose 17% YoY to approximately RMB19.468 billion.The company also announ......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

US-Iran nuclear talks yielded no results, and the US announced it would block the Strait of Hormuz. Market rumors later suggested a new round of US-Iran talks could be held within days. Hong Kong equities declined today (13th). US March YoY inflation rose to 3.3%, in line with expectations. US stocks showed mixed performance las......